The Scleroderma Research Foundation is the largest nonprofit investor in scleroderma research in the United States, focused on finding a cure for this rare autoimmune disease. The foundation promotes collaboration among leading scientists and medical institutions to advance innovative therapies.
1987
68-0087234
$11.14 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
This annual comedy event raises funds for scleroderma research and also honors influential figures in the entertainment industry.
Individuals can help advance research for scleroderma by participating in clinical studies.
A comprehensive overview of the foundation's activities, financial highlights, and impact stories.
1,000th Patient Enrolled in CONQUER
Major milestone for the nation's only longitudinal scleroderma patient registry.
$1.2 Million Raised for Research (2024)
Funds raised from the 'Cool Comedy • Hot Cuisine' event supporting scleroderma research.
Over $40 Million Committed to Research
Financial commitment to advancing scleroderma research projects.
November 8, 2023
Cool Comedy • Hot Cuisine 2023 raised significant funds to support research.
October 29, 2024
Join us for a night of laughter and support for scleroderma research.
Learn MoreResearch project focusing on health disparities affecting African American scleroderma patients.
Learn MoreJoin dedicated volunteers to raise awareness and funds for scleroderma research.
Learn MoreOverall Score
69
58
/100
Program Expense Ratio
80.28%
12
/20
Program Revenue Growth
1.04K%
2
/20
Leverage Ratio
0.1114
18
/20
Working Capital Ratio
2.126
14
/20
Fundraising Efficiency
1.389
12
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 5.377M | 91.24% |
Program Services | 170.5K | 2.89% |
Investment Income | 116.8K | 1.98% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 16.53K | 0.28% |
Total Revenue | 5.893M | 100.00% |
Med Research
Lung Disease ResearchMed Research
Lung Disease ResearchMed Research
Lung Disease ResearchMed Research
Lung Disease ResearchMed Research
Lung Disease Research